Document:

Exhibit 10.35

 

Healthnet
Assessments Inc.

119
Westcreek Drive, Suite 4

Woodbridge,
Ontario L4L 9N6

 

November
2, 2021

 

James
Asher, President

Novo
Healthnet Limited

3905
Major Mackenzie Drive, Suite 115

Woodbridge,
Ontario L4H 4R2

 

	SUBJ:	CAD$2,000,000
    Series ‘“A” Debenture, dated September 30, 2013, Extension of Term Due Date to December 1, 2023

 

Dear
Mr. Asher,

 

We
want to thank you for your communication of September 28, 2021 in which your company, Novo Healthnet Limited, requested an extension
of full and final payment with respects to the Series “A” Debenture, dated September 30, 2013 (the “Debenture”),
with an original principal amount of CAD$2,000,000 and an original term due date of September 30, 2016.

 

On
December 2, 2017, the parties agreed to extend the term due date, for payment of the Debentures’ principal and interest owed, to
September 30, 2019. On January 31, 2018, the parties agreed to convert 75% of the Debenture amount owed, both principal and interest,
into shares of common stock (par value $0.001) of Novo Healthnet Limited’s parent company, Novo Integrated Sciences, Inc., a Nevada
corporation, in lieu of accepting a cash payment for 75% of the amount owed, both principal and interest. On September 27, 2019, the
parties agreed to extend the term due date, for payment of the Debentures’ principal and interest owed, to September 30, 2021.

 

Effective
November 2, 2021, Healthnet Assessments Inc. agrees to extend the term due date for payment of the Debentures’ principal and interest
owed, to December 1, 2023, with no penalties incurred and with all terms and conditions, as defined in the Debenture, remaining in full
force and effect.

 

	APPROVED	 	 
	 	 	 
	Debenture
    Holder	 	Debenture
    Issuer
	Healthnet
    Assessments Inc.	 	Novo
    Healthnet Limited
	 	 	 
	/s/
    Robert Mattacchione	 	/s/
    James Asher
	Robert
    Mattacchione	 	James
    Asher
	Authorized
Signing Officer
	 	Authorized
    Signing OfficerExhibit
10.36

 

ICC
Healthnet Canada Inc.

119
Westcreek Drive, Suite 4

Woodbridge,
Ontario L4L 9N6

 

November
2, 2021

 

James
Asher, President

Novo
Healthnet Limited

3905
Major Mackenzie Drive, Suite 115

Woodbridge,
Ontario L4H 4R2

 

	SUBJ:	CAD$3,000,000
    Series ‘“A” Debenture, dated September 30, 2013, Extension of Term Due Date to December 1, 2023

 

Dear
Mr. Asher,

 

We
want to thank you for your communication of September 28, 2021 in which your company, Novo Healthnet Limited, requested an extension
of full and final payment with respects to the Series “A” Debenture, dated September 30, 2013 (the “Debenture”),
with an original principal amount of CAD$3,000,000 and an original term due date of September 30, 2016.

 

On
December 2, 2017, the parties agreed to extend the term due date, for payment of the Debentures’ principal and interest owed, to
September 30, 2019. On January 31, 2018, the parties agreed to convert 75% of the Debenture amount owed, both principal and interest,
into shares of common stock (par value $0.001) of Novo Healthnet Limited’s parent company, Novo Integrated Sciences, Inc., a Nevada
corporation, in lieu of accepting a cash payment for 75% of the amount owed, both principal and interest. On September 27, 2019, the
parties agreed to extend the term due date, for payment of the Debentures’ principal and interest owed, to September 30, 2021.

 

Effective
November 2, 2021, ICC Healthnet Canada Inc. agrees to extend the term due date for payment of the Debentures’ principal and interest
owed, to December 1, 2023, with no penalties incurred and with all terms and conditions, as defined in the Debenture, remaining in full
force and effect.

 

	APPROVED	 	 
	 	 	 
	Debenture
    Holder	 	Debenture
    Issuer
	ICC
    Healthnet Canada Inc.	 	Novo
    Healthnet Limited
	 	 	 
	/s/
    Robert Mattacchione	 	/s/
    James Asher
	Robert
    Mattacchione	 	James
    Asher
	Authorized
Signing Officer
	 	Authorized
    Signing OfficerExhibit
10.37

 

Peak
Health LTC Inc.

1425
Front Street, P. O. Box 2230

Hearst
Ontario P0L 1N0

 

November
2, 2021

 

Robert
Mattacchione, Chairman

Novo
Healthnet Limited

3905
Major Mackenzie Drive, Suite 115

Woodbridge,
Ontario L4H 4R2

 

	SUBJ:	CAD$314,519.70
    Series “A” Debenture, dated September 30, 2013, Extension of Term Due Date to December 1, 2023

 

Dear
Mr. Mattacchione,

 

We
want to thank you for your communication of September 28, 2021 in which your company, Novo Healthnet Limited, requested an extension
of final payment with respects to the Series “A” Debenture, dated September 30, 2013 (the “Debenture”), with
an original principal amount of CAD$314,519.70 and an original term due date of September 30, 2016.

 

On
December 2, 2017, the parties agreed to extend the term due date, for payment of the Debentures’ principal and interest owed, to
September 30, 2019. On January 31, 2018, the parties agreed to convert 75% of the Debenture amount owed, both principal and interest,
into shares of common stock (par value $0.001) of Novo Healthnet Limited’s parent company, Novo Integrated Sciences, Inc., a Nevada
corporation, in lieu of accepting a cash payment for 75% of the amount owed, both principal and interest. On September 27, 2019, the
parties agreed to extend the term due date, for payment of the Debentures’ principal and interest owed, to September 30, 2021.

 

Effective
November 2, 2021, Peak Health LTC Inc. agrees to extend the term due date for payment of the Debentures’ principal and interest
owed, to December 1, 2023, with no penalties incurred and with all terms and conditions, as defined in the Debenture, remaining in full
force and effect.

 

	APPROVED	 	 
	 	 	 
	Debenture
    Holder	 	Debenture
    Issuer
	Peak
    Health LTC Inc.	 	Novo
    Healthnet Limited
	 	 	 
	/s/
    Dr. Pierre Dalcourt	 	/s/
    Robert Mattacchione
	Dr.
    Pierre Dalcourt	 	Robert
    Mattacchione
	Authorized
Signing Officer
	 	Authorized
    Signing OfficerExhibit
10.38

 

Michael
Gaynor Physiotherapy Professional Corporation

49
Balmoral Street

Kemptville,
Ontario Canada K0G 1J0

 

November
2, 2021

 

Robert
Mattacchione, Chairman

Novo
Healthnet Limited

3905
Major Mackenzie Drive, Suite 115

Woodbridge,
Ontario L4H 4R2

 

	SUBJ:	CAD$387,992.14
    Series ‘“A” Debenture, dated September 30, 2013, Extension of Term Due Date to December 1, 2023

 

Dear
Mr. Mattacchione,

 

We
want to thank you for your communication of September 28, 2021 in which your company, Novo Healthnet Limited, requested an extension
of final payment with respects to the Series “A” Debenture, dated September 30, 2013 (the “Debenture”), with
an original principal amount of CAD$387,992.14 and an original term due date of September 30, 2016.

 

On
December 2, 2017, the parties agreed to extend the term due date, for payment of the Debentures’ principal and interest owed, to
September 30, 2019. On January 31, 2018, the parties agreed to convert 75% of the Debenture amount owed, both principal and interest,
into shares of common stock (par value $0.001) of Novo Healthnet Limited’s parent company, Novo Integrated Sciences, Inc., a Nevada
corporation, in lieu of accepting a cash payment for 75% of the amount owed, both principal and interest. On September 27, 2019, the
parties agreed to extend the term due date, for payment of the Debentures’ principal and interest owed, to September 30, 2021.

 

Effective
November 2, 2021, Michael Gaynor Physiotherapy Professional Corporation agrees to extend the term due date for payment of the Debentures’
principal and interest owed, to December 1, 2023, with no penalties incurred and with all terms and conditions, as defined in the Debenture,
remaining in full force and effect.

 

	APPROVED	 	 
	 	 	 
	Debenture
    Holder	 	Debenture
    Issuer
	Michael
    Gaynor Physiotherapy	 	Novo
    Healthnet Limited
	Professional
    Corporation	 	 
	 	 	 
	/s/
    Michael Gaynor	 	/s/
    Robert Mattacchione
	Michael
    Gaynor	 	Robert
    Mattacchione
	Authorized
Signing Officer
	 	Authorized
    Signing OfficerExhibit
10.39

 

Peak
Health LTC Inc.

1425
Front Street, P. O. Box 2230

Hearst
Ontario P0L 1N0

 

November
2, 2021

 

Robert
Mattacchione, Chairman

Novo
Healthnet Limited

3905
Major Mackenzie Drive, Suite 115

Woodbridge,
Ontario L4H 4R2

 

	SUBJ:	CAD$700,000
    Series ‘“A” Debenture, dated January 3, 2014, Extension of Term Due Date to December 1, 2023

 

Dear
Mr. Mattacchione,

 

We
want to thank you for your communication of September 28, 2021 in which your company, Novo Healthnet Limited, requested an extension
of final payment with respects to the Series “A” Debenture, dated January 3, 2014 (the “Debenture”), with an
original principal amount of CAD$700,000 and an original term due date of September 30, 2016.

 

On
December 2, 2017, the parties agreed to extend the term due date, for payment of the Debentures’ principal and interest owed, to
September 30, 2019. On January 31, 2018, the parties agreed to convert 75% of the Debenture amount owed, both principal and interest,
into shares of common stock (par value $0.001) of Novo Healthnet Limited’s parent company, Novo Integrated Sciences, Inc., a Nevada
corporation, in lieu of accepting a cash payment for 75% of the amount owed, both principal and interest. On September 27, 2019, the
parties agreed to extend the term due date, for payment of the Debentures’ principal and interest owed, to September 30, 2021.

 

Effective
November 2, 2021, Peak Health LTC Inc. agrees to extend the term due date for payment of the Debentures’ principal and interest
owed, to December 1, 2023, with no penalties incurred and with all terms and conditions, as defined in the Debenture, remaining in full
force and effect.

 

	APPROVED	 	 
	 	 	 
	Debenture
    Holder	 	Debenture
    Issuer
	Peak
    Health LTC Inc.	 	Novo
    Healthnet Limited
	 	 	 
	/s/
    Dr. Pierre Dalcourt	 	/s/
    Robert Mattacchione
	Dr.
    Pierre Dalcourt	 	Robert
    Mattacchione
	Authorized
Signing Officer
	 	Authorized
    Signing Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]